LAWRENCE ROBINSON: Open Payments
NPI 1649248592 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$873 in 32 payments from 11 companies in 2025. Trend: 2023 $625 · 2024 $0 · 2025 $873
Food & beverage: $873
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $208 |
| ABBVIE INC. | 8 | $207 |
| Organon LLC | 5 | $125 |
| Regeneron Healthcare Solutions, Inc. | 2 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $58 |
| Lilly USA, LLC | 2 | $44 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
| Incyte Corporation | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Biofrontera Inc. | 1 | $21 |
Products named: TREMFYA, RINVOQ, LIBTAYO, HADLIMA, SKYRIZI, ILUMYA, TALTZ, VTAMA.
Industry payments across WA — which companies pay providers there.
